Campaigners warn that EU trade deal with US could threaten drug pricesBMJ 2014; 349 doi: https://doi.org/10.1136/bmj.g6098 (Published 07 October 2014) Cite this as: BMJ 2014;349:g6098
- Rory Watson
The European Union is coming under pressure to ensure that any trade agreements it enters do not undermine national public health services and to lift the secrecy surrounding the negotiations. The demands coincide with the imminent appointment of a new EU trade commissioner, Cecilia Malmström, and against the background of extensive talks with the United States on a transatlantic free trade area.
In a wide ranging report Oxfam and Health Action International Europe claimed that the potential EU-US agreement, known as the Transatlantic Trade and Investment Partnership (TTIP), could pose a serious threat to public health in Europe and set dangerous precedents for future trade deals between the EU and developing countries.1
Leïla Bodeux, Oxfam’s policy adviser, said, …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial